Neurovalens raised €5.4M in a Series A round in Jan 2019. The company is based in Belfast, Ireland. Investors in the round: Wharton Asset Management. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €5.4M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
